erosclerosis [2] [3] [4] and in patients with end-stage renal reported that a high titer of serum anti-oxLDL antibody was an independent predictor of a low risk for cardiovascular death disease (ESRD) [5] . In contrast, studies in familial hyperin patients with end-stage renal disease (ESRD). In the present cholesterolemia [6] showed that those patients having study, we examined a possible association between anti-oxLDL had a myocardial infarction had a lower anti-oxidized antibody titer and arterial wall thickness in ESRD patients.
LDL antibody titer than those who had not had a myo-
Methods. The subjects were 103 ESRD patients treated with hemodialysis. A high resolution B-mode ultrasound method was cardial infarction. We [7] found in healthy subjects that oxidized LDL antibody was an independent predictor of Conclusion. These results show for the first time that titer a low risk for cardiovascular mortality in ESRD patients.
of anti-oxLDL antibody is an independent factor inversely assoThese results raise the possibility that antibody to oxiciated with arterial thickness in ESRD, supporting the concept dized LDL has a protective role against atherosclerosis that immunity against oxLDL plays an anti-atherogenic role.
in ESRD patients as well as in the healthy population.
The purpose of this study was to examine the relationship between anti-oxidized LDL antibody titer and arteOxidized low-density lipoprotein (LDL) plays a central role in the development of atherosclerosis. LDL rial wall thickness in ESRD patients. from the circulation enters the arterial wall and is oxidized in the subendothelium. Oxidized LDL in the arte-METHODS rial wall may be taken up by macrophages, resulting in foam cell formation and fatty streak lesions, or it may Subjects diffuse back into the circulation. So far, it is not well The subjects were 103 nondiabetic ESRD patients understood what factors regulate or affect the fate of who were treated with maintenance hemodialysis in the oxidized LDL.
morning sessions. They were randomly selected from our Since oxidized LDL is highly antigenic, immune reclinical database as those patients who had been measponse to oxidized LDL may modulate the metabolism sured for CA-IMT, FA-IMT, and serum anti-oxidized LDL antibody all at the same time. The clinical charac- 
Measurement of intima-media thickness
CA-IMT and FA-IMT were measured by high-resolution B-mode ultrasonography using a real-time ultrasonograph with a 10-MHz in-line Sectascanner, as described previously [11] . We took the greatest thickness of intimamedia complex, including plaques, if any, as IMT for analysis. The examination included approximately 4 cm of the common carotid artery, the carotid bulb, and 1 cm each of the internal and external carotid arteries. The femoral artery was examined distal to the inguinal inverse association remained significant in multiple religament at the site where the artery divides into the gression analysis including age, gender, hypertension, superficial and the profound femoral arteries, and dyslipidemia, smoking, and duration of dialysis (Table 2) . scanned approximately 4 cm proximal and 1 cm distal
The antibody titer had an inverse trend with CA-IMT to the flow divider.
but it was not statistically significant.
Anti-oxidized LDL antibody and other measurements
Blood was drawn in the morning after an overnight DISCUSSION fast of at least 12 hours before starting a dialysis sesWe found in the present study that anti-oxidized LDL sion. Serum IgG-class anti-oxidized LDL antibody was antibody titer inversely correlated with FA-IMT, and measured by ELISA using a commercially available kit that the antibody titer showed a similar trend with (OLAB; Biomedica, Vienna, Austria), as previously de-CA-IMT. This is the first study that has examined the scribed [7, 8] . Antibody titer was calculated by conrelationship between anti-oxidized LDL antibody titer structing a standard curve using the standards included and thickness of arterial wall in patients with ESRD. in the kit and expressed in the unit defined by the manuSome previous studies showed elevated titer of antifacturer. Other measurements were by routine methods. oxidized LDL antibody in ESRD patients [5] and in those with advanced atherosclerosis [2] [3] [4] . Because oxiStatistical methods dized LDL is a causative factor of atherosclerosis, the Correlation between two variables was evaluated by raised antibody titer was believed to mirror the increased simple regression analysis. Independent association beoxidized LDL in vivo and, therefore, an atherogenic tween variables was assessed by multiple regression analcondition. However, in later studies, anti-oxidized LDL ysis. P values less than 0.05 were considered statistically antibody inversely correlated with plasma oxidized LDL significant.
concentration [7] , CA-IMT [8], in the healthy population. The present study has confirmed the RESULTS inverse association of anti-oxidized LDL antibody titer with FA-IMT in ESRD patients. Although the correlaSerum anti-oxidized LDL antibody showed a significant and inverse correlation with FA-IMT (Fig. 1) . The tion between the antibody titer and CA-IMT did not 
